ā Back to Trial
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
Trial Locations
-
Stanford Cancer Institute
Stanford, California, United States
- Contact: David Marcellus
-
East Jefferson General Hospital
River Ridge, Louisiana, United States
- Contact: Clarity Pharmaceuticals Ā· +61 (0) 2 9209 4037 Ā· [email protected] (opens in new tab)
-
BAMF Health
Grand Rapids, Michigan, United States
- Contact: Clarity Pharmaceuticals Ā· +61 (0) 2 9209 4037 Ā· [email protected] (opens in new tab)
-
Mayo Clinic
Rochester, Minnesota, United States
- Contact: Clarity Pharmaceuticals Ā· +61 (0) 2 9209 4037 Ā· [email protected] (opens in new tab)
-
Washington University School of Medicine at Barnes-Jewish Hospital
St Louis, Missouri, United States
- Contact: Clarity Pharmaceuticals Ā· +61 (0) 2 9209 4037 Ā· [email protected] (opens in new tab)
-
XCancer
Omaha, Nebraska, United States
- Contact: Tony Romero Ā· 402-690-3716 Ā· [email protected] (opens in new tab)
-
Weill Cornell Medicine at New York-Presbyterian
New York, New York, United States
- Contact: Clarity Pharmaceuticals Ā· +61 (0) 2 9209 4037 Ā· [email protected] (opens in new tab)

